Using AI and high-throughput T-cell screening, Sift is developing a new class of T-cell modulators to treat cancers and autoimmune diseases.
Org chart
Collapse
No reports!
Teams
Offices
This company has no offices yet
SERHANT.
13 followers
Ministère de l'Intérieur
5 followers
Highways England
4 followers
T
The Lede Company
4 followers
NHSRCL
3 followers
AfterQuery
3 followers
east bay regional park district
2 followers
Flourish Research
2 followers
NAV
1 follower
Cville City Schools
1 follower
Data Literacy Academy
1 follower
AIM Intelligent Machines
1 follower